Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Py

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 29, 2018
Choosing Wisely, another way to spread blood transfusion's good practicesJean-Yves Py
Blood Transfusion = Trasfusione Del Sangue|July 15, 2016
Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance surveyPierre Moncharmont, Grégory Barday, Jean-Yves Py, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 30, 2020
Are single-donor red blood cell transfusions still relevant for preterm infants?Elodie Gouache, Jean-Yves Py, Béatrice Hérault, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 29, 2007
[Future technological evolutions in blood donation qualification]Azzedine Assal, Jean-Yves Py, Cécile Corbi, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 21, 2003
Risk target: an interactive context factor in risk perceptionDanièle Hermand, Serge Karsenty, Yves Py, et al.
Transfusion Medicine Reviews|May 2, 2022
Hypersensitivity transfusion reactions to fresh frozen plasma: a retrospective analysis of the French hemovigilance networkCharles Tacquard, Georges Andreu, Nicolas Meyer, et al.
Transfusion Medicine Reviews|February 7, 2025
Platelet Additive Solutions and Pathogen Reduction Impact on Transfusion Safety, Patient Management and Platelet SupplyGeorges Andreu, Karim Boudjedir, Nicolas Meyer, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 3, 2007
[Evaluation of the professional practices of physicians in transfusion technology and medicine]Eric Hergon, Jean-Yves Py, Stéphanie Jullien, et al.
Vox Sanguinis|September 11, 2023
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillanceSyria Laperche, Claire Sauvage, Pierre Gallian, et al.
Transfusion|August 7, 2020
Pathogenic and likely pathogenic variants in at least five genes account for approximately 3% of mild isolated nonsyndromic thrombocytopeniaPaul Guéguen, Arnaud Dupuis, Jean-Yves Py, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 29, 2018
Choosing Wisely, another way to spread blood transfusion's good practicesJean-Yves Py
Blood Transfusion = Trasfusione Del Sangue|July 15, 2016
Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance surveyPierre Moncharmont, Grégory Barday, Jean-Yves Py, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 30, 2020
Are single-donor red blood cell transfusions still relevant for preterm infants?Elodie Gouache, Jean-Yves Py, Béatrice Hérault, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 29, 2007
[Future technological evolutions in blood donation qualification]Azzedine Assal, Jean-Yves Py, Cécile Corbi, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 21, 2003
Risk target: an interactive context factor in risk perceptionDanièle Hermand, Serge Karsenty, Yves Py, et al.
Transfusion Medicine Reviews|May 2, 2022
Hypersensitivity transfusion reactions to fresh frozen plasma: a retrospective analysis of the French hemovigilance networkCharles Tacquard, Georges Andreu, Nicolas Meyer, et al.
Transfusion Medicine Reviews|February 7, 2025
Platelet Additive Solutions and Pathogen Reduction Impact on Transfusion Safety, Patient Management and Platelet SupplyGeorges Andreu, Karim Boudjedir, Nicolas Meyer, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 3, 2007
[Evaluation of the professional practices of physicians in transfusion technology and medicine]Eric Hergon, Jean-Yves Py, Stéphanie Jullien, et al.
Vox Sanguinis|September 11, 2023
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillanceSyria Laperche, Claire Sauvage, Pierre Gallian, et al.
Transfusion|August 7, 2020
Pathogenic and likely pathogenic variants in at least five genes account for approximately 3% of mild isolated nonsyndromic thrombocytopeniaPaul Guéguen, Arnaud Dupuis, Jean-Yves Py, et al.
Pageof 2